AI Medical Compendium Journal:
Current breast cancer reports

Showing 1 to 1 of 1 articles

Extended Adjuvant Aromatase Inhibitor Therapy in Post-Menopausal Women.

Current breast cancer reports
PURPOSE OF THE REVIEW: To understand the evidence for extending adjuvant aromatase inhibitor (AI) therapy from 5 to 10 years in post-menopausal women with hormone receptor positive (HR+) breast cancer.